Onyx Biotec Limited
Onyx Biotech Ltd manufactures and sells Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas, through a B2B business model
What Onyx files
- Others28
- Updates9
- Board Meeting9
- Important5
- Insider Trade5
- Results2
Company has announced a board meeting to consider the financial results for the quarter and half-year. The Board will also consider raising funds up to 400 Cr via a preferential issue of equity shares or other convertible securities.
Onyx Biotec clarified recent share price movement. The company is unaware of the reasons, stating it's purely market-driven, and management is not connected to the price action.
Onyx Biotec's promoter sold 1,774,000 equity shares in an on-market transaction valued at INR 5.44 Cr. This reduced the promoter's stake from 21.48% to 11.70%, signaling a notable change in shareholding structure.
Onyx Biotec Ltd. has entered into a manufacturing agreement with Galpha Laboratories Limited for the production of Dry Powder Injection. This collaboration aims to enhance Onyx's product offerings in the biopharmaceutical market. The agreement does not involve any shareholding connection between the two parties, nor does it classify as a...
Onyx Biotec Ltd. has announced a board meeting, where the unaudited standalone financial results for the half year are reported. Total income for the half-year ended September 30, 2024, reached ₹3,113.67 crore, marking an increase from ₹2,392.78 crore in the corresponding period last year, representing a revenue growth of 30.1%....